Perspective Therapeutics (CATX US)

Perspective Therapeutics, Inc. operates as a biotech company. The Company develops cesium-131 brachytherapy seeds and has a proprietary technology that utilizes the isotope lead-212 to deliver powerful alpha radiation specifically to cancer cells via specialized targeting peptides. Perspective Therapeutics serves customers worldwide.